Status:

ACTIVE_NOT_RECRUITING

RESOLUTE ONYX China Single Arm Study

Lead Sponsor:

Medtronic Vascular

Conditions:

Ischemic Heart Disease

Stenotic Coronary Lesion

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous transluminal coron...

Detailed Description

This study is a pre-Market, prospective, multi-center, single arm trial. Subjects will be enrolled and followed through 5 Years (screen, implant procedure(including post-procedure assessment),30-Day, ...

Eligibility Criteria

Inclusion

  • Key
  • The subject is an acceptable candidate for treatment with a drug-eluting stent in accordance with the applicable guidelines on percutaneous coronary interventions, and the IB of Resolute Onyx stent.
  • The subject requires treatment of up to 3 target lesions in up to 2 separate target vessels \[2 target lesions in 1 vessel (including its side branches) and 1 target lesion in a separate vessel (including its side branches)\] amenable to treatment with stents with diameter from 2.25 mm to 5.0 mm
  • Key

Exclusion

  • Known hypersensitivity or contraindication to aspirin, heparin, bivalirudin, P2Y12 inhibitors, mTOR inhibiting drugs such as zotarolimus, Biolimus A9 (or its derivatives), cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (e.g. BioLinx) or a sensitivity to contrast media, which cannot be adequately pre-medicated
  • PCI of the target vessel within 9 months prior to the procedure
  • Active bleeding
  • Subjects with a life expectancy of less than 12 months
  • Participation in another clinical study
  • Pregnant, or lactating women

Key Trial Info

Start Date :

March 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2026

Estimated Enrollment :

591 Patients enrolled

Trial Details

Trial ID

NCT03471845

Start Date

March 30 2018

End Date

April 30 2026

Last Update

November 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Affiliated Hospital of Jiangsu University

Zhenjiang, Jiangsu, China